Original Research
Accepted on 06 Oct 2025
Benralizumab for Adults with Rare and Off-Label Eosinophilic disorders: a 52-week Prospective, Single-Center Study
in Inflammation
Original Research
Accepted on 06 Oct 2025
in Inflammation
Systematic Review
Accepted on 06 Oct 2025
in Organizational Psychology
Case Report
Accepted on 06 Oct 2025
in Genetics of Common and Rare Diseases
Case Report
Accepted on 06 Oct 2025
in Genetics of Common and Rare Diseases
Case Report
Accepted on 06 Oct 2025
in Genetics of Common and Rare Diseases
Original Research
Accepted on 06 Oct 2025
in Genetics of Common and Rare Diseases
Original Research
Accepted on 06 Oct 2025
in Pathology
Original Research
Accepted on 06 Oct 2025
in Pathology
Perspective
Accepted on 06 Oct 2025
in Healthcare Professions Education
Original Research
Accepted on 06 Oct 2025
in Hematology
Study Protocol
Published on 06 Oct 2025
in Breast Cancer
Original Research
Published on 06 Oct 2025
in Food Microbiology
Original Research
Published on 06 Oct 2025
in Water and Climate
Original Research
Published on 06 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 06 Oct 2025
in Drugs Outcomes Research and Policies
Original Research
Published on 06 Oct 2025
in Coral Reef Research